elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37859778-3CA0814A-3E60-49BF-8F5E-5657E20A05DD
Q37859778-3CA0814A-3E60-49BF-8F5E-5657E20A05DD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37859778-3CA0814A-3E60-49BF-8F5E-5657E20A05DD
Lipid-lowering effects of ezetimibe and simvastatin in combination.
P2860
Q37859778-3CA0814A-3E60-49BF-8F5E-5657E20A05DD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37859778-3CA0814A-3E60-49BF-8F5E-5657E20A05DD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2fc8ea37db67b604d9a1d48bd4a86142cd8532f9
P2860
Combination therapy with ezetimibe and simvastatin to achieve aggressive LDL reduction.